DailyDoctor Archive Specialties Get app
Back to the 4 October 2026 edition

Clinical update · 01 of 06

Antidepressants linked to higher ventricular arrhythmia risk

Factor cardiac risk into antidepressant choice, favouring lower-QT agents in people with heart disease, but treat the depression rather than leaving it untreated.

Design
Systematic review and meta-analysis of 12 cohort and case-control studies; random-effects odds ratios
Population
9,619,278 antidepressant users vs non-users
Primary outcome
Atrial fibrillation and ventricular arrhythmia or sudden cardiac death
Effect
Ventricular arrhythmia or sudden cardiac death odds ratio 1.34 (1.15 to 1.55), I-squared 90.5 percent

Twelve observational studies covering 9,619,278 people were pooled to test whether antidepressant use tracks with cardiac arrhythmia. Use was associated with a higher risk of ventricular arrhythmia or sudden cardiac death — odds ratio 1.34 (95% CI 1.15 to 1.55) across nine studies and 6.4 million people — and the association held for both SSRIs and tricyclics.

The atrial fibrillation picture was less clear. The overall estimate was not significant and was dominated by one study; a sensitivity analysis removing it gave a smaller significant association and removed the heterogeneity. Heterogeneity was otherwise very high, and confounding by indication — depression itself raises cardiac risk — is the central limitation the authors flag.

For practice, this is a reason for vigilance, not for withholding treatment. Weigh cardiac risk when choosing an agent, favour drugs with less QT effect in people with cardiac disease, and treat the depression — which carries its own cardiac risk — rather than leaving it untreated.

  • Twelve studies, 9,619,278 people; ventricular arrhythmia or sudden cardiac death odds ratio 1.34 (95% CI 1.15 to 1.55).
  • The arrhythmia association held for both SSRIs and tricyclics.
  • Atrial fibrillation showed no stable overall association (odds ratio 1.75, 0.84 to 3.62) and rested on a single influential study.
  • In people with cardiac disease, weigh QT effect when choosing an agent and review co-prescribed QT-prolonging drugs.
  • Do not withhold treatment on this: untreated depression carries its own cardiac risk.

Why it matters

It presses the choice of antidepressant in a patient with cardiac disease, without being a reason to leave depression untreated.

Don't overread it

This was observational with very high heterogeneity and likely confounding by indication — it shows an association, not that antidepressants cause arrhythmia.

The statistics, in plain English

An odds ratio of 1.34 with an interval entirely above 1.0 is statistically significant, but an I-squared of 90 percent means the studies disagreed sharply, so the pooled figure is unstable; because this is observational, the depression being treated — not the drug — may be driving much of the risk.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

depressionsuicidebipolar

Tomorrow morning, before your first patient

One edition a day for psychiatry, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app